Prosper AI
AI voice agents for patient access and revenue cycle telephony. The distinguishing capability is direction: alongside patient facing calls for scheduling, intake, and billing questions, the agents call payers directly, navigating IVR trees, waiting on hold, and speaking with representatives to obtain benefits and prior authorization details when electronic eligibility transactions return incomplete data, then writing structured results back to the EHR or practice management system. Every call is automatically reviewed by AI for accuracy and compliance rather than by manual audit. The vendor reports reaching more than 150,000 healthcare providers and cites roughly three week implementation. Founded 2023; raised a $30 million Series A led by Andreessen Horowitz in 2026, following a $5 million seed.
Capability Axes
Conversational voice agents are the entire product. There is no non AI version of an agent that navigates a payer IVR, holds, and speaks with a representative.
The agents operate autonomously on live payer and patient calls, and the vendor's oversight mechanism is automated quality assurance review of every call for accuracy and compliance rather than human sampling. That is a real control and unusual to state. Held back from A because escalation thresholds, failure handling, and what happens when the agent obtains incorrect benefits information are not documented publicly, and the consequences of an error on a benefits call are financial and fall on the patient.
Adoption figures are reported (more than 150,000 providers reached, 40 to 60 care organizations depending on source) and revenue growth is claimed at 5x since seed. However the operative metrics for this category, containment rate and benefits accuracy, appear only as vendor claims such as 99 percent QA accuracy, without published methodology or independent validation. The company is early: founded 2023, Series A in 2026.
API first integration with practice management and EHR systems, with the agents reading from and writing back to those systems rather than operating alongside them, and a reported three week implementation. Named EHR marketplace listings or certifications were not verified.
No public pricing. Contact the vendor. Sold through enterprise agreements with provider groups and billing organizations; no published rate card.
Clearly scoped to outpatient groups, medical billing organizations, and health system patient access and revenue cycle functions, spanning scheduling, intake, benefits verification, prior authorization, claim follow up, and billing. Clear operational scope; no clinical claims made, which is appropriate.
Pricing
Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.
| Entry Price | Pricing Basis | BAA Tier | Implementation | Source |
|---|---|---|---|---|
|
Contact the vendor
|
Enterprise agreements with provider groups and billing organizations | — | — | Vendor Published |
Enterprise agreements with provider groups, health systems, and medical billing organizations. No rate card published. Buyers should establish whether pricing is per call, per agent, or per seat, since that materially changes economics for a telephony product.